HormoneSynergy vs SkyRx: Prices, Programs & Reviews (2026)
Side-by-side comparison updated for 2026. ClearScores, pricing, medications, and ratings compared.
HormoneSynergy starts at $300/mo and SkyRx at $299/mo. SkyRx scores higher on our ClearScore (70 vs 75), and SkyRx is the cheaper starting option.
Quick Verdict
SkyRx has the higher ClearScore (75 vs 70)
SkyRx is more affordable ($299/mo vs $300/mo)
HormoneSynergy has higher ratings (4.6/5 vs 4.4/5)
HormoneSynergy scores better on value (4.1/5 vs 3.6/5)
HormoneSynergy
$300/mo
starting price
Longevity-focused GLP-1 program with DEXA scans, CGM, and hormone optimization in Portland, OR.
SkyRx
$299/mo
starting price
Premium GLP-1 program with full labs, high-touch clinician access, and both semaglutide and tirzepatide.
HormoneSynergy vs SkyRx: Full Comparison
| HormoneSynergy | SkyRx | |
|---|---|---|
| ClearScore | 70/100 | 75/100 ✓ |
| Overall Rating | 4.6/5 ✓ | 4.4/5 |
| Review Count | 42 | 58 ✓ |
| Starting Price | $300/mo | $299/mo ✓ |
| Medications | Semaglutide, Tirzepatide | Compounded Semaglutide, Compounded Tirzepatide |
| Telehealth | No | Yes |
| Insurance | Not accepted | Not accepted |
| HSA/FSA | Not accepted | Accepted |
| Founded | 2006 | 2022 |
| States Served | 1 states | All 50 states |
Programs & Pricing
HormoneSynergy Programs
Weight Loss for Longevity
From $300/mo
Medications: Semaglutide, Tirzepatide
- Medication
- Dexa Scans
- Cgm Monitoring
- Hormone Optimization
SkyRx Programs
Premium Weight Loss
$299/mo
Medications: Compounded Semaglutide, Compounded Tirzepatide
- Medication
- Full Labs
- Dedicated Clinician
- Priority Support
Ratings Breakdown
| Category | HormoneSynergy | SkyRx |
|---|---|---|
| Overall | | |
| Value | | |
| Ease of Use | | |
| Support | | |
| Medication Quality | | |
| Results | | |
The Bottom Line
SkyRx edges out HormoneSynergy with a ClearScore of 75 vs 70. SkyRx is more affordable starting at $299/mo compared to $300/mo. For customer support, SkyRx rates higher (4.8/5). The best choice depends on your priorities, medication preferences, and budget.